Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance (Q42511030)

1 November 2017

Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance (English)

1 reference

1 November 2017

R Millon

1

1 reference

1 November 2017

D Muller

2

1 reference

1 November 2017

I Schultz

3

1 reference

1 November 2017

R Salvi

4

1 reference

1 November 2017

J P Ghnassia

5

1 reference

1 November 2017

T Frebourg

6

1 reference

1 November 2017

B Wasylyk

7

1 reference

1 November 2017

J Abecassis

8

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

1 November 2017

1 reference

1 November 2017

37

1 reference

1 November 2017

620-631

1 reference

1 November 2017

8

1 reference

The MDM2 gene amplification database

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Mdm2 promotes the rapid degradation of p53

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Interaction between the retinoblastoma protein and the oncoprotein MDM2

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

p53 overexpression in head and neck squamous cell carcinoma: review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Twenty years of p53 research: structural and functional aspects of the p53 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

p53 and MDM2 expression in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Immunophenotypic analysis of normal mucosa and squamous cell carcinoma of the oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

New insights into p53 protein stabilisation in oral squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Infrequent MDM2 gene amplification and absence of gross WAF1 gene alterations in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

A simple p53 functional assay for screening cell lines, blood, and tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Apoptosis-associated proteins and the development of oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Detection of MDM2-proto-oncogene in paraffin embedded human bronchial epithelium.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

MDM-2 protein is expressed in different layers of normal human skin

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Regulation of p53 stability by Mdm2

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

MDM2 expression during mouse embryogenesis and the requirement of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

mdm 2 mRNA expression is associated with survival in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

mdm2 mRNA level is a prognostic factor in soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2800%2900122-6

7 January 2021

10.1016/S1368-8375(00)00122-6

Identifiers

DOI

1 reference

1 November 2017

1 reference